Dimensional Fund Advisors LP Nurix Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

$418 Billion
Q2 2025

A detailed history of Dimensional Fund Advisors LP transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 427,071 shares of NRIX stock, worth $4.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

427,071

Previous 575,312 25.77%

Holding current value

$4.28 Million

Previous $6.83 Million 28.83%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$8.81 - $12.79 $1.31 Million - $1.9 Million	-148,241 Reduced 25.77%	427,071 $4.86 Million
Q1 2025 May 13, 2025	BUY	$11.88 - $20.15 $813,459 - $1.38 Million	68,473 Added 13.51%	575,312 $6.83 Million
Q4 2024 Feb 13, 2025	BUY	$18.64 - $28.14 $98,232 - $148,297	5,270 Added 1.05%	506,839 $9.55 Million
Q3 2024 Nov 07, 2024	SELL	$18.93 - $25.69 $1.92 Million - $2.61 Million	-101,564 Reduced 16.84%	501,569 $11.3 Million
Q2 2024 Aug 09, 2024	SELL	$12.02 - $21.3 $4.37 Million - $7.74 Million	-363,320 Reduced 37.59%	603,133 $12.6 Million
Q1 2024 May 10, 2024	SELL	$7.77 - $15.66 $261,002 - $526,035	-33,591 Reduced 3.36%	966,453 $14.2 Million
Q4 2023 Feb 07, 2024	BUY	$4.25 - $10.71 $178,504 - $449,830	42,001 Added 4.38%	1,000,044 $10.3 Million
Q3 2023 Nov 09, 2023	BUY	$7.86 - $10.08 $1.42 Million - $1.82 Million	180,531 Added 23.22%	958,043 $7.53 Million
Q2 2023 Aug 09, 2023	BUY	$8.7 - $13.28 $1.25 Million - $1.91 Million	143,995 Added 22.73%	777,512 $7.77 Million
Q1 2023 May 12, 2023	BUY	$8.56 - $13.26 $426,074 - $660,016	49,775 Added 8.53%	633,517 $5.63 Million
Q4 2022 Feb 09, 2023	BUY	$9.86 - $14.59 $2.46 Million - $3.63 Million	249,017 Added 74.39%	583,742 $6.41 Million
Q3 2022 Nov 10, 2022	BUY	$12.33 - $19.81 $1.61 Million - $2.58 Million	130,423 Added 63.84%	334,725 $4.36 Million
Q2 2022 Aug 12, 2022	SELL	$7.88 - $14.82 $261,797 - $492,364	-33,223 Reduced 13.99%	204,302 $2.59 Million
Q1 2022 May 13, 2022	BUY	$12.94 - $29.65 $1.57 Million - $3.59 Million	121,167 Added 104.13%	237,525 $3.33 Million
Q4 2021 Feb 09, 2022	BUY	$26.43 - $34.5 $3.08 Million - $4.01 Million	116,358 New	116,358 $3.37 Million

Others Institutions Holding NRIX

# of Institutions

174

Shares Held

79.4M

Call Options Held

126K

Put Options Held

11.3K

View Full List

About Nurix Therapeutics, Inc.

Ticker NRIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,147,800
Market Cap $472M
Description
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...

More about NRIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Nurix Therapeutics, Inc. Transaction History